focus -WSS

focus

author：comprehensive 2025-09-30 18:21:14 - browse：446

On Tuesday, Google DeepMind and Isomorphic Labs announced a significant progress update on the next iteration of AlphaFold, the deep learning model that in 2020 cracked the problem of predicting a protein’s structure from its amino acid sequence, leapfrogging other approaches in computational biology.

Now, the companies say they have developed the model to predict not just standalone protein structures, but what proteins look like in combination with several classes of molecules, including small molecules and nucleic acids — capabilities that are key for drug development.

“We really needed to make progress on protein-ligand binding and co-folding of ligands with proteins in order to help us design more effective drugs,” said Demis Hassabis, CEO of both DeepMind and Isomorphic Labs, which spun out in 2021 with the goal of applying deep learning approaches to drug discovery. The updated model can also predict protein structures after they’ve been modified. “Basically the new AlphaFold can cope with all of these different things, which is pretty amazing.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Biden’s NIH nominee is languishing in Congress

WSS

PEPFAR is under serious threat — and so is global health

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

ACA's risk program benefits Blue Cross Blue Shield insurers

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

PEPFAR is under serious threat — and so is global health

White House touts steps to stem shortages of cancer treatments

explore

focus

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

23andMe had bad news about my health. I wish a person had delivered it

PEPFAR is under serious threat — and so is global health

Sports medicine is finally prioritizing gender equality

IRA could hurt research into orphan drugs for rare diseases

After affirmative action ruling, medical educators look to 'holistic review'

FDA proposes changes to key medical devices approval pathway

Tori Bowie and the unacceptable rates of Black maternal death

How medical schools plan to diversify without affirmative action

explore

Acelyrin, a rare IPO success, stumbles in its first big test

FDA panel endorses Alnylam’s heart drug — after picking it apart

Telehealth for opioid use disorder is lifesaving

Regeneron agrees to White House price limits on anti

Recent heat wave in the Mediterranean caused by climate change: Study

Home health providers sue Medicare over payment cuts

Wikipedia

hotspot

focus

knowledge